To provide the right treatment for MS, it is important to know when the disease changes from relapsing-remitting to secondary progressive, a transition that is currently recognized on average three years too late. Researchers have now developed an AI model that can determine with 90 per cent certainty which variant the patient has.
http://news.poseidon-us.com/TKVZBQLike this:
Like Loading...
Related
